Position in ZVRA
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,802,560
+$137,920 QoQ
Shares Held
408,000
-0.2% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stratos Wealth Partners, LTD. holds $11,734,127 across 20 Biotechnology names. ZVRA ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
408,000 | $3,802,560 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,299 | $1,473,135 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
100,000 | $1,111,000 | |
| 4 | PLX |
Protalix BioTherapeutics, Inc.
|
500,000 | $1,085,000 | |
| 5 | INCY |
Incyte Corp
|
6,895 | $648,957 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,715 | $579,319 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,640 | $493,086 | |
| 8 | EXEL |
Exelixis, Inc.
|
9,093 | $389,998 |
All Filings in ZVRA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,802,560 | 408,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,664,640 | 409,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,177,790 | 229,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,938,200 | 220,000 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,321,900 | 310,000 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,800,905 | 335,840 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,905,361 | 418,640 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $344,176 | 70,240 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $407,392 | 70,240 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $460,072 | 70,240 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $338,364 | 70,200 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $358,020 | 70,200 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $386,100 | 70,200 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $322,218 | 70,200 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $438,048 | 70,200 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $314,684 | 70,557 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $354,952 | 70,567 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $625,874 | 71,857 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $662,028 | 70,957 | Shares | Sole | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||